|
PF-34066 |
LISORET Comprimidos Recubiertos |
2009-09-23 |
|
Mercantil Farmaceutica S.A. |
Guatemala
|
Mefasa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55449 |
POSTELLE Comprimidos Recubiertos |
2023-07-03 |
|
Urufarma S.A. |
Uruguay
|
Dalt Pharma |
Coidesa. |
Amicelco |
Befasa |
Resco |
Avanter |
Asta Médica Centroamericana |
Servicio De Comercio Internacional |
Droguería Colón |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
PF-58907 |
MECUIDO 1.50 mg Comprimido |
2026-01-15 |
|
Biomed Pharma |
Uruguay
|
PPSA |
Biomed Pharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-59167 |
GESELLE-28 Comprimidos recubiertos |
2026-03-15 |
|
Biomed Pharma |
Uruguay
|
PPSA |
Biomed Pharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-59848 |
GENOBELLE-21 Comprimidos recubiertos |
2026-08-13 |
|
Biomed Pharma |
Uruguay
|
PPSA |
Biomed Pharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-34041 |
TOBE 2.5 mg comprimido Recubierto (simple) |
2014-09-21 |
|
Laboratorio Chile S.A. |
Chile
|
Amicelco |
Droguería Colón |
Droguería Médica Internacional |
Bodega Farmacéutica, S.A. |
Agefinsa (Agencia Farm. Intern., S.A.) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-52310 |
SALOME ® Comprimido recubierto |
2025-12-18 |
|
Urufarma S.A. |
Uruguay
|
Dalt Pharma |
Coidesa. |
Amicelco |
Befasa |
Resco |
Avanter |
Asta Médica Centroamericana |
Servicio De Comercio Internacional |
Droguería Colón |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
PF-52959 |
SECURITY DAY Tableta |
2026-07-07 |
|
Droguería Europharma |
Uruguay
|
Droguería Europharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-54741 |
MIRANDA Comprimidos recubiertos |
2022-12-08 |
|
Laboratorio Elea S.A.C.I.F y A |
Uruguay
|
Befasa |
Altian Pharma |
Asta Médica Centroamericana |
Droguería Y Farmacia Lanquetin |
La Botica |
Farbiox |
Bodega Farmacéutica, S.A. |
Droguería Latinoamericana |
Codister |
Centro Distribuidor, S.A. |
|
|
|
|
|
|
|
|
|
|
|
PF-56760 |
EVYFEM 0.1 mg /0.02 mg Comprimidos |
2024-05-28 |
|
Droguería Europharma |
Uruguay
|
Droguería Europharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|